Dissolvable film BNT23001 led to about 40% higher cladribine exposure than tablets in a preclinical pig study, BioNxt ...

Sai Parenteral Limited and Hella Infra Market have received final approval for their IPOs from Sebi. Sai Parenteral's ...

LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...

Initiation of phase 1 portion of the trial planned in 2H 2026-Phase 2 portion of the trial will initiate development of the elraglusib tablet in ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized ...

What motivated the shift into the veterinary space? Topelius: Actually, we started with veterinary applications. When we founded the company, our first application areas w ...

This approval allows Bionpharma to commercialize the product in the United States, expanding patient access to a more ...

TRS offers a robust solution for analyzing heterogeneous samples, providing comprehensive spectral data essential for ...

With ANDA approval secured, Bionpharma will lead the commercialization and distribution of Etravirine tablets in the United States. Both organizations view this achievement as a solid foundation for ...

Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...

Mind Medicine has altered its state, rebranding as Definium Therapeutics ahead of a series of phase 3 data drops on its lead ...